
7.67 Delayed Data As of Mar 31 | ![]() Today’s Change | 6.31 Today|||52-Week Range 15.25 | -20.35% Year-to-Date |
ProPhase Labs, Inc. (PRPH) Reports Q4 Loss, Tops Revenue Estimates Mar 28 / Zacks.com - Paid Partner Content |
Previous close | 7.46 |
Today’s open | 7.60 |
Day’s range | 7.55 - 7.72 |
Volume | 920 |
Average volume (3 months) | 53,032 |
Market cap | $132.0M |
Earnings growth (last year) | +181.79% |
Earnings growth (this year) | -97.55% |
Earnings growth (next 5 years) | +1.00% |
Revenue growth (last year) | +55.17% |
P/E ratio | 7.5 |
Price/Sales | 1.46 |
Price/Book | 1.96 |
Today’s change | Today’s % change | |
---|---|---|
EPIXESSA Pharma Inc | 0.00 | 0.00% |
MISTMilestone Pharmaceut... | +0.15 | +3.92% |
EYENEyenovia Inc | +0.36 | +11.32% |
MDWDMediwound Ltd | +0.22 | +1.66% |
Next reporting date | May 16, 2023 |
EPS forecast (this quarter) | -$0.09 |
Annual revenue (last year) | $122.6M |
Annual profit (last year) | $18.5M |
Net profit margin | 15.05% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Garden City, New York |